Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Rosuvastatin for Reducing Blood Clots in Patients with Deep Vein Thrombosis or Pulmonary Embolism

    Recruiting

    3 1 1
    Investigated Drugs:
    France Norway
  • Study on the Effectiveness of Oxygen for Patients with Intermediate-Risk Acute Pulmonary Embolism

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Spain
  • Study on Monitoring vs. Rivaroxaban for Patients with Low-Risk Isolated Subsegmental Pulmonary Embolism

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France The Netherlands
  • Study on the Best Antithrombotic Therapy for Patients with Acute Venous Thromboembolism Using Tinzaparin Sodium and Drug Combination

    Recruiting

    3 1 1 1
    France
  • Study on Treatments for Intermediate High-Risk Pulmonary Embolism: Comparing Percutaneous Embolectomy, Ultrasound-Assisted Thrombolysis with Alteplase, and Heparin

    Recruiting

    3 1 1 1
    Denmark
  • Enoxaparin or drug combination versus no anticoagulant treatment for incidental subsegmental pulmonary embolism in cancer patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Denmark
  • Study on Lung Function After Pulmonary Embolism Using Galligas and 68Ga-MAA in Patients with Pulmonary Embolism

    Not yet recruiting

    1 1 1 1
    France
  • Study of Catheter-Directed Thrombolysis Using Alteplase for Treatment of Intermediate-High Risk Acute Pulmonary Embolism

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia
  • Study on Sulodexide for Preventing Recurrence of Blood Clots in Elderly Patients After First Episode of Deep Vein Thrombosis or Pulmonary Embolism

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study on Reduced Dose of Alteplase for Patients with Intermediate-High-Risk Acute Pulmonary Embolism

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria France Germany Italy The Netherlands Poland +2